Due to decentralized and hybrid designs, the growing clinical trial complexity generates vast data volumes from diverse sources and creates significant data management challenges. In response, sponsors are increasingly employing unified clinical data and analytics (D&A) platforms to centralize and standardize clinical data to gain actionable insights, offering real-time monitoring, predictive analytics, and risk management. These platforms transform disparate datasets into cohesive, structured formats, allowing stakeholders to detect outliers, predict adverse events, and generate on-demand dashboards and reports.
D&A platforms offer centralized repositories, Risk-Based Quality Management (RBQM), and seamless integration with Electronic Health Records (EHRs), wearables, and medical devices. These features improve data access and interoperability, contributing to more informed decision-making and enhanced quality and risk oversight. Clinical D&A platform providers are incorporating cutting-edge AI and generative AI capabilities to automate repetitive tasks, generate insights, and strengthen quality and risk management to address sponsor needs.
-
Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024
What is in this PEAK Matrix® Report
In this report, we analyze 18 clinical D&A platform providers featured on the Everest Group’s PEAK Matrix® based on their capabilities, offerings, and market impact. The report will empower buyers to choose the right provider for their sourcing considerations and enable providers to benchmark themselves against their competition.
Content:
In this report, we:
- Examine the provider landscape for clinical D&A platforms
- Assess clinical D&A platform providers on capabilities and market success-related dimensions
- Position the providers on Everest Group’s PEAK Matrix® framework as Leaders, Major Contenders, and Aspirants
- Compare providers’ key strengths and limitations
Scope:
- Industry: life sciences
- Geography: global
READ ON
-
Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2023
What is in this PEAK Matrix® Report
In this report, we assess 14 clinical Data and Analytics (D&A) platform providers. The providers are positioned on Everest Group’s PEAK Matrix®, a composite index of a range of distinct metrics related to the providers’ capabilities and market impact. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other.
Content:
In this report, we:
- Examine the provider landscape for clinical D&A platforms
- Assess clinical D&A platform providers on several capabilities and market success-related dimensions
Scope:
- Industry: life sciences
- Geography: global
READ ON
What is the PEAK Matrix®?
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
